We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Severe congenital neutropenia due to G6PC3 deficiency: early and delayed phenotype of a patient

    Background

    Severe Congenital Neutropenia type 4 (SCN4), is a rare autosomal recessive condition, due to mutations in the G6PC3 gene. The phenotype...

    Negar Moradian, Samaneh Zoghi, ... Nima Rezaei in Allergy, Asthma & Clinical Immunology
    Article Open access 09 June 2023
  2. Extracorporeal membrane oxygenation in long-term COVID-19 with severe neutropenia and thrombocytopenia after allogeneic hematopoietic stem cell transplantation: a case report

    Background

    Hematopoietic stem cell transplantation (HSCT) was associated with potentially life-threatening complications. Among patients supported by...

    Shiqi Guo, Linna Zhang, ... Qiang Guo in BMC Infectious Diseases
    Article Open access 20 February 2024
  3. Non-cancer febrile neutropenia in children: pathogens, antimicrobial susceptibilities, and outcomes

    Background

    Febrile neutropenia is a medical emergency and remains a significant cause of morbidity and mortality, it is defined as a...

    Radwa Abdel-Raheem Radwan, Ilham Youssry, ... Eman Abdel El Raouf Mohammed in Egyptian Pediatric Association Gazette
    Article Open access 07 June 2024
  4. Incidence, predictors, and outcomes of febrile neutropenia and neutropenia in patients with metastatic castrate-resistant prostate cancer receiving docetaxel

    Purpose

    The incidence of febrile neutropenia (FN) in adults with castrate-resistant metastatic prostate cancer (mCRPC) receiving docetaxel in...

    Sophie Peltekian, Shellyza Sajwani, ... Salmaan Kanji in Supportive Care in Cancer
    Article 01 May 2023
  5. Paediatric autoimmune diseases with ELANE mutations associated with neutropenia

    Objective

    To explore the clinical characteristics of autoimmune diseases in children with ELANE mutations.

    Methods

    Three cases of children with ELANE...

    Dan Zhang, Gaixiu Su, ... Shunqiao Feng in Pediatric Rheumatology
    Article Open access 28 April 2023
  6. The prevalence of neutropenia and association with infections in patients with systemic lupus erythematosus: a Swedish single-center study conducted over 14 years

    Hematologic abnormalities are common manifestations of SLE, although neutropenia is observed less frequently and is not included in the...

    Muna Saleh, Johanna Sjöwall, ... Christopher Sjöwall in Rheumatology International
    Article Open access 19 March 2024
  7. Genetic susceptibility to breast cancer increases the risk of neutropenia and agranulocytosis: insights from Mendelian randomization

    Purpose

    The causal relationship between breast cancer and its estrogen receptor (ER) subtypes and neutropenia and agranulocytosis is unclear.

    ...
    Changlong Wei, Gongyin Zhang, ... **sheng Zeng in Supportive Care in Cancer
    Article 29 June 2024
  8. Clinical significance of human neutrophil antigen-1 antibodies in children with neutropenia

    Primary autoimmune neutropenia in young children is characterized by chronic neutropenia and positivity for antibodies against human neutrophil...

    Satoshi Goda, Shuhei Karakawa, ... Masao Kobayashi in International Journal of Hematology
    Article 21 September 2023
  9. What is the role of neutropenia in pediatric cancer patients with pneumatosis intestinalis?

    Background

    We aimed to identify prognostic indicators in pneumatosis intestinalis (PI) in a pediatric oncology population. We hypothesized that...

    Shannon N. Acker, Sarah Ogle, ... Ann M. Kulungowski in Pediatric Surgery International
    Article 23 May 2023
  10. A prospective, real-world, multinational study of febrile neutropenia (FN) occurrence in oncology patients receiving chemotherapy with intermediate risk of FN: a MASCC Neutropenia, Infection, and Myelosuppression Study Group initiative

    Purpose

    Limited knowledge is available on the incidence of febrile neutropenia (FN) in intermediate-risk patients and the rationale for use of...

    Bernardo Leon Rapoport, Marcial Garcia-Morillo, ... Jean Klastersky in Supportive Care in Cancer
    Article Open access 13 October 2023
  11. Cyclic neutropenia and concomitant IgA nephropathy: a case report

    Background

    IgA nephropathy (IgAN) is universally recognized as one of the most common primary glomerular diseases in all ages. Cyclic neutropenia (CN)...

    C. Kapogiannis, T. Zaggogianni, ... C. Kanaka-Gantenbein in BMC Nephrology
    Article Open access 03 May 2023
  12. New approaches to idiopathic neutropenia in the era of clonal hematopoiesis

    Isolated chronic idiopathic neutropenia (CIN) is a rare disease with multiple contributing etiologies that must be ruled out before establishing a...

    Olisaemeka D. Ogbue, Tariq Kewan, ... Jaroslaw P. Maciejewski in Experimental Hematology & Oncology
    Article Open access 28 April 2023
  13. CT-determined sarcopenia is associated with neutropenia in patients undergoing hyperthermic intraperitoneal chemotherapy for gastrointestinal cancer

    Background

    With better patient selection and the increasing experience in patients undergoing hyperthermic intraperitoneal chemotherapy (HIPEC)...

    Wei Jiang, Wenli Zhan, ... Zhixin Cao in World Journal of Surgical Oncology
    Article Open access 22 February 2023
  14. Effect of lithium on chemotherapy-induced neutropenia in Egyptian breast cancer patients; a prospective clinical study

    Purpose

    Myelosuppressive chemotherapy-induced neutropenia (CIN) remains a major limitation of cancer treatment efficacy, necessitating very expensive...

    Ahmed O. ELKasar, Fatma Z. Hussien, ... Adel R. Abd-Allah in Cancer Chemotherapy and Pharmacology
    Article 07 February 2024
  15. Efbemalenograstim alfa, an Fc fusion protein, long-acting granulocyte-colony stimulating factor for reducing the risk of febrile neutropenia following chemotherapy: results of a phase III trial

    Purpose

    Evaluate the safety and efficacy of efbemalenograstim alfa for reducing the risk of febrile neutropenia in breast cancer patients undergoing...

    John Glaspy, Igor Bondarenko, ... Simon Li in Supportive Care in Cancer
    Article Open access 16 December 2023
  16. Overexposure to venetoclax is associated with prolonged-duration of neutropenia during venetoclax and azacitidine therapy in Japanese patients with acute myeloid leukemia

    Purpose

    An observational study was conducted to evaluate the pharmacokinetics of venetoclax and its impact on the efficacy and safety for Japanese...

    Takahiro Kobayashi, Honami Sato, ... Naoto Takahashi in Cancer Chemotherapy and Pharmacology
    Article 23 May 2024
  17. Low utilization of vancomycin in febrile neutropenia: real-world evidence from 4 Brazilian centers

    Purpose

    The prompt initiation of a betalactam antibiotic in febrile neutropenic patients is considered standard of care, while the empiric use of...

    Jessica Fernandes Ramos, André Domingues Pereira, ... Celso Arrais Rodrigues in Supportive Care in Cancer
    Article 10 November 2023
  18. Ambulatory management of low-risk febrile neutropenia in adult oncological patients. Systematic review

    Purpose

    Recent clinical practice guidelines have recommended ambulatory management of febrile neutropenia in patients with low risk of complications....

    Ester Forcano-Queralt, Cristina Lemes-Quintana, Domingo Orozco-Beltrán in Supportive Care in Cancer
    Article Open access 01 November 2023
  19. Prevalence of neutropenia in US residents: a population based analysis of NHANES 2011–2018

    Aims

    Neutrophils play a pivotal in immunity and inflammation. We aim to investigate the prevalence of neutropenia in the United States.

    ...
    **g Zhou, Nan Zhou, ... Li-Da Wu in BMC Public Health
    Article Open access 28 June 2023
  20. Quality of life and patient-reported outcomes in chronic severe neutropenia conditions

    Quality of life (QOL) and patient-reported outcomes (PROs) assessments in immunodeficiency patients, including those with chronic severe neutropenia...

    Thomas F. Michniacki, Lauren E. Merz, ... Kelly Walkovich in International Journal of Hematology
    Article 15 February 2021
Did you find what you were looking for? Share feedback.